When Retatrutides weight loss curve flattens, adding AOD-9604 introduces a new stimulus that the body has not adapted to yet
Ghrelin Receptor (GHS-R1a) Selective Activation Ipamorelin acts as a highly selective agonist of the growth hormone secretagogue receptor (GHS-R1a), mimicking the natural hormone ghrelin without affecting other pituitary hormone secretion: Selective binding to GHS-R1a receptors without stimulating ACTH, cortisol, or prolactin release Rapid onset of growth hormone pulse generation (peak levels within 40-60 minutes) No significant effect on appetite stimulation unlike other ghrelin mimetics Preserved feedback regulation through endogenous growth hormone-releasing inhibitory mechanisms Research indicates that ipamorelin releases growth hormone with potency and efficacy similar to GHRP-6 (EC50 approximately 1.3 nmol/L) but with superior selectivity for growth hormone secretion
Research applications Tendon-fibroblast outgrowth and migration assays, in-vitro angiogenesis (HUVEC tube-formation), gastrointestinal mucosal-repair models, NO-pathway interaction studies, and growth-factor expression screens
Molecular Profile Molecular Weight 1,419.53 Da Sequence GEPPPGKPADDAGLV (15 amino acids) Purity Spec 98% by HPLC Storage Store lyophilized at 20C
What is the Wolverine Stack and how is it different from BPC-157 alone
This includes exercise recovery, chronic inflammation, tendon or ligament strain, and general wear and tear
